Cargando…
Advances in molecular infectious diseases testing in the time of COVID-19
The Coronavirus Disease of 2019 (COVID-19) pandemic has been a challenging event for laboratory medicine and diagnostics manufacturers. We have had to confront numerous unique and previously unthinkable issues on a daily basis in order to continue offering diagnostic testing for not only Severe Acut...
Autores principales: | Peaper, David R., Kerantzas, Christopher A., Durant, Thomas J.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Canadian Society of Clinical Chemists. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843810/ https://www.ncbi.nlm.nih.gov/pubmed/35181291 http://dx.doi.org/10.1016/j.clinbiochem.2022.02.005 |
Ejemplares similares
-
Advancement in POCT Molecular Testing: The Multiplex PCR POCT Devices for Infectious Diseases
por: Alp, Alpaslan
Publicado: (2018) -
Pyomyositis and Infectious Myositis: A Comprehensive, Single-Center Retrospective Study
por: Radcliffe, Christopher, et al.
Publicado: (2021) -
Molecular Testing in Emerging Infectious Diseases
por: Dong, J., et al.
Publicado: (2017) -
Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application
por: Kerantzas, Christopher A., et al.
Publicado: (2017) -
Recent Advances in Biochemistry and Molecular Biology of Infectious Diseases
por: De-Simone, Salvatore Giovanni
Publicado: (2023)